Simplifying Global Compliance
FDAnews Device Daily Bulletin
Brainsway Starts Bipolar Disorder Trial
Aug. 21, 2012
Brainsway has begun a second multicenter trial of its deep TMS (transcranial magnetic stimulation) device for the treatment of bipolar disorder (manic depression). Sunday, the company announced it had signed with 18 medical centers in Israel, Canada, and the U.S.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing